Indaptus Therapeutics, Inc. (INDP): Total Assets
$9.31M
As of 2025-12-31
$11.99M
As of 2026-06-30
-30.8%
3-year compound annual growth
+39.3%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.31M | +26.9% | 2026-03-17, Balance as of period end |
| 2024-12-31 | $7.34M | -50.8% | 2026-03-17, Balance as of period end |
| 2023-12-31 | $14.92M | -46.8% | 2025-03-13, Balance as of period end |
| 2022-12-31 | $28.06M | -30.8% | 2024-03-13, Balance as of period end |
| 2021-12-31 | $40.58M | n/m | 2023-03-17, Balance as of period end |
| 2020-12-31 | $1.78M | n/a | 2022-03-21, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | 2025-12-31 | $9.31M | +26.9% |
| Soligenix, Inc. (SNGX) | 2025-12-31 | $9.24M | +3.0% |
| ProMIS Neurosciences Inc. (PMN) | 2025-12-31 | $9.18M | -51.4% |
| Kala Bio, Inc. (KALA) | 2025-12-31 | $9.49M | -82.9% |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $9.51M | +4.3% |
| FibroBiologics, Inc. (FBLG) | 2025-12-31 | $9.62M | -41.5% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $8.97M | +26.9% |
| MAIA Biotechnology, Inc. (MAIA) | 2025-12-31 | $9.70M | -4.4% |
| Cocrystal Pharma, Inc. (COCP) | 2025-12-31 | $9.71M | -27.8% |
Compare INDP, SNGX, PMN, KALA side by side · Screen every company in Pharmaceutical Preparations ↗